Skip to main content
. 2021 Mar 23;23(9):1446–1455. doi: 10.1093/europace/euab028

Table 2.

PADIT risk score component distribution in Data Sets A, B, and PADIT study

PADIT risk score component PADIT risk score points Data Set A (N = 32 464) (%) Data Set B (N = 21 578) (%) PADIT study (N = 19 559) (%)
Age
 <60 2 4228 (13.0) 2777 (12.9) 3096 (15.8)
 60–69 1 6271 (19.3) 4173 (19.3) 4244 (21.7)
 ≥70 0 21 965 (67.6) 14 628 (67.8) 12 219 (62.5)
Procedure type
 Pacemaker 0 16 729 (51.5) 11 127 (51.6) 48.9
 ICD 2 6625 (20.4) 4455 (20.7) 21.6
 CRT 4 3704 (11.4) 2491 (11.5) 16.2
 Revision/upgrade 4 5406 (16.7) 3505 (16.2) 15.3
Renal insufficiency 1 9043 (27.9) 6100 (28.3) 16.7
Immunocompromised 3 2019 (6.2) 1324 (6.1) 1.6
Prior procedure(s)a
 None 0 20 017 (61.7) 13 349 (61.9) 9056 (46.3)
 One 1 11 880 (36.6) 7866 (36.5) 7851 (40.1)
 Two or more 3 567 (1.8) 363 (1.7) 2652 (13.6)
History of CIED infection N/A 368 (1.1) 217 (1.0) 0
a

Prior procedure(s) is inclusive of all procedures including de novo implant.

CIED, cardiac implantable electronic device; CRT, cardiac resynchronization therapy; ICD, implantable cardioverter-defibrillator; PADIT, Prevention of Arrhythmia Device Infection Trial.